ASCO Daily News

A podcast by American Society of Clinical Oncology (ASCO)

134 Episodes

  1. ASCO23: Novel Approaches in RCC, mUC, and Prostate Cancer

    Published: 5/25/2023
  2. ASCO23: CodeBreak-101, NAPOLI-3, and Other Advances in GI Cancers

    Published: 5/25/2023
  3. ASCO23: Novel Therapies in Lung Cancer 

    Published: 5/25/2023
  4. ASCO23: PALMIRA, LEONARDA-1, and Other Advances in Breast Cancer

    Published: 5/25/2023
  5. ASCO23: Key Abstracts from Precision Oncology to Cancer Disparities

    Published: 5/25/2023
  6. S2302 Pragmatica-Lung and the Promise of Streamlined Clinical Trials

    Published: 4/13/2023
  7. Advances in Neoadjuvant IO in MSI-H/dMMR Colorectal Cancer

    Published: 3/16/2023
  8. Key Abstracts in Prostate, Bladder, and Kidney Cancers at GU23

    Published: 3/2/2023
  9. ARASENS, TRITON3, and Other Key Advances at GU23

    Published: 2/13/2023
  10. SWOG 1815, PARADIGM, and Other Advances at GI23

    Published: 2/2/2023
  11. Fertility Concerns, Family Planning, and Career Decisions Among Female Oncologists

    Published: 1/5/2023
  12. What Challenges Will Oncologists Face in 2023?

    Published: 12/8/2022
  13. Developing the Next Generation of Prostate Cancer Researchers

    Published: 11/15/2022
  14. Novel Therapies Targeting KRAS in Lung Cancer & RAS-Altered Tumors

    Published: 11/3/2022
  15. Advancing Equity and Quality Cancer Care at #ASCOQLTY22

    Published: 10/14/2022
  16. The Impact of Hurricane Ian on Cancer Care

    Published: 10/12/2022
  17. How Primary Tumor Sidedness Impacts Treatment and Other Advances in Colorectal Cancer

    Published: 9/15/2022
  18. Update from Poland: Cancer Care for Ukrainian Refugees

    Published: 8/11/2022
  19. A Novel Approach to Address Financial Toxicity

    Published: 7/28/2022
  20. Hidden Gems From ASCO22: Abstracts on EDI, Health Care Economics, and More

    Published: 7/14/2022

4 / 7

The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.